Cargando…
Cryopreservation of human colorectal carcinomas prior to xenografting
BACKGROUND: Molecular heterogeneity of colorectal carcinoma (CRC) is well recognized, forming the rationale for molecular tests required before administration of some of the novel targeted therapies that now are rapidly entering the clinics. For clinical research at least, but possibly even for futu...
Autores principales: | Linnebacher, Michael, Maletzki, Claudia, Ostwald, Christiane, Klier, Ulrike, Krohn, Mathias, Klar, Ernst, Prall, Friedrich |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910693/ https://www.ncbi.nlm.nih.gov/pubmed/20615215 http://dx.doi.org/10.1186/1471-2407-10-362 |
Ejemplares similares
-
Ex-vivo Clonally Expanded B Lymphocytes Infiltrating Colorectal Carcinoma Are of Mature Immunophenotype and Produce Functional IgG
por: Maletzki, Claudia, et al.
Publicado: (2012) -
Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment
por: Prall, Friedrich, et al.
Publicado: (2017) -
Tumor Take Rate Optimization for Colorectal Carcinoma Patient-Derived Xenograft Models
por: Gock, Michael, et al.
Publicado: (2016) -
Establishment, Characterization and Chemosensitivity of Three Mismatch Repair Deficient Cell Lines from Sporadic and Inherited Colorectal Carcinomas
por: Maletzki, Claudia, et al.
Publicado: (2012) -
Host defense peptides for treatment of colorectal carcinoma – a comparative in vitro and in vivo analysis
por: Maletzki, Claudia, et al.
Publicado: (2014)